Literature DB >> 27544138

What's new in refractory status epilepticus?

Stephane Legriel1,2, Mauro Oddo3, Gretchen M Brophy4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27544138     DOI： 10.1007/s00134-016-4501-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  16 in total

1.  A randomized trial for the treatment of refractory status epilepticus.

Authors:  Andrea O Rossetti; Tracey A Milligan; Serge Vulliémoz; Costas Michaelides; Manuel Bertschi; Jong Woo Lee
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

2.  High-dose midazolam infusion for refractory status epilepticus.

Authors:  Andres Fernandez; Hector Lantigua; Christine Lesch; Belinda Shao; Brandon Foreman; J Michael Schmidt; Lawrence J Hirsch; Stephan A Mayer; Jan Claassen
Journal:  Neurology       Date:  2013-12-20       Impact factor: 9.910

3.  Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety.

Authors:  Flavio Bellante; Benjamin Legros; Chantal Depondt; Jacques Créteur; Fabio Silvio Taccone; Nicolas Gaspard
Journal:  J Neurol       Date:  2016-02-25       Impact factor: 4.849

4.  Ketogenic diet for adults in super-refractory status epilepticus.

Authors:  Kiran T Thakur; John C Probasco; Sara E Hocker; Kelly Roehl; Bobbie Henry; Eric H Kossoff; Peter W Kaplan; Romergryko G Geocadin; Adam L Hartman; Arun Venkatesan; Mackenzie C Cervenka
Journal:  Neurology       Date:  2014-01-22       Impact factor: 9.910

5.  What's new in status epilepticus?

Authors:  Andrea O Rossetti; Thomas P Bleck
Journal:  Intensive Care Med       Date:  2014-06-13       Impact factor: 17.440

Review 6.  Propofol versus thiopental sodium for the treatment of refractory status epilepticus.

Authors:  Hemanshu Prabhakar; Mani Kalaivani
Journal:  Cochrane Database Syst Rev       Date:  2015-06-25

7.  Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane.

Authors:  Seyed M Mirsattari; Michael D Sharpe; G Bryan Young
Journal:  Arch Neurol       Date:  2004-08

8.  Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study.

Authors:  Nicolas Gaspard; Brandon Foreman; Lilith M Judd; James N Brenton; Barnett R Nathan; Blathnaid M McCoy; Ali Al-Otaibi; Ronan Kilbride; Ivan Sánchez Fernández; Lucy Mendoza; Sophie Samuel; Asma Zakaria; Giridhar P Kalamangalam; Benjamin Legros; Jerzy P Szaflarski; Tobias Loddenkemper; Cecil D Hahn; Howard P Goodkin; Jan Claassen; Lawrence J Hirsch; Suzette M Laroche
Journal:  Epilepsia       Date:  2013-06-12       Impact factor: 5.864

9.  High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit.

Authors:  I Parviainen; A Uusaro; R Kälviäinen; E Kaukanen; E Mervaala; E Ruokonen
Journal:  Neurology       Date:  2002-10-22       Impact factor: 9.910

Review 10.  Neuroprotective effect of therapeutic hypothermia versus standard care alone after convulsive status epilepticus: protocol of the multicentre randomised controlled trial HYBERNATUS.

Authors:  Stephane Legriel; Fernando Pico; Yves-Roger Tran-Dinh; Virginie Lemiale; Jean-Pierre Bedos; Matthieu Resche-Rigon; Alain Cariou
Journal:  Ann Intensive Care       Date:  2016-06-21       Impact factor: 6.925
View more
  5 in total

1.  Focus on the brain and systemic organ systems: when essential interactions become toxic relationships.

Authors:  M Smith; G Meyfroidt
Journal:  Intensive Care Med       Date:  2018-11-05       Impact factor: 17.440

2.  Super-refractory status epilepticus: epidemiology, early predictors, and outcomes.

Authors:  Anne-Laure Chateauneuf; Jean-Denis Moyer; Gwenaelle Jacq; Sébastien Cavelot; Jean-Pierre Bedos; Stephane Legriel
Journal:  Intensive Care Med       Date:  2017-05-11       Impact factor: 17.440

3.  Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study.

Authors:  Anne-Mari Kantanen; Reetta Kälviäinen; Ilkka Parviainen; Marika Ala-Peijari; Tom Bäcklund; Juha Koskenkari; Ruut Laitio; Matti Reinikainen
Journal:  Crit Care       Date:  2017-03-23       Impact factor: 9.097

4.  Early Combination Therapy of Ketamine and Midazolam in Patients with Refractory Status Epilepticus in Hemodynamic Unstable State.

Authors:  Jung-Won Choi; Jung-Won Shin
Journal:  J Epilepsy Res       Date:  2021-12-31

5.  Multicentre observational status-epilepticus registry: protocol for ICTAL.

Authors:  Gwenaelle Jacq; Jonathan Chelly; Jean-Pierre Quenot; Pauline Soulier; Olivier Lesieur; Pascal Beuret; Mathilde Holleville; Cedric Bruel; Pierre Bailly; Bertrand Sauneuf; Caroline Sejourne; Jean Philippe Rigaud; Arnaud Galbois; Marine Arrayago; Gaetan Plantefeve; Annabelle Stoclin; David Schnell; Candice Fontaine; François Perier; Wulfran Bougouin; Nicolas Pichon; Nicolas Mongardon; Didier Ledoux; Jean-Baptiste Lascarrou; Stephane Legriel
Journal:  BMJ Open       Date:  2022-02-15       Impact factor: 2.692
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.